METHOD FOR TREATING INFLAMMATORY INTESTINAL DISEASES

medicine, pharmacology. SUBSTANCE: it is suggested to apply kappa-agonist of opiatic receptors of N-methyl-N[(1S-)-1- phenyl-2-((3S)-3-oxypyrrolidine-1-il)-ethyl] -2.2-diphenyl- acetamide hydrochloride to treat inflammatory intestinal diseases. The compound does not only treat the pain and discomfor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOTTSHLIKH RUDOL'F, BARBER EHNDRJU, ZEJFRID KRISTOF, BARTOSHIK GERD
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine, pharmacology. SUBSTANCE: it is suggested to apply kappa-agonist of opiatic receptors of N-methyl-N[(1S-)-1- phenyl-2-((3S)-3-oxypyrrolidine-1-il)-ethyl] -2.2-diphenyl- acetamide hydrochloride to treat inflammatory intestinal diseases. The compound does not only treat the pain and discomfort as a result of broken intestinal motor system but has a direct antiphlogistic action, as well. EFFECT: increased number of preparations of mentioned indication. 9 ex